Expression and significances of apoptosis gene, invasion associated proteases and vascular epithelial growth factor in Lauren's classification of gastric carcinoma
- Author:
- No author available
- Journal Title:
- WORLD CHINESE JOURNAL OF DIGESTOLOGY
- Issue:
- 16
- DOI:
- 10.3969/j.issn.1009-3079.2006.16.006
- Key Word:
- Bcl;Bax;Cath-D;血管内皮生长因子;胃癌;生物行为;Lauren's分型
Abstract： 目的:从"肿瘤异质化"角度出发,通过多种基因编码蛋白(Bcl-2/Bax,Cath-D和VEGF)在肠型胃癌和弥漫型胃癌中的表达,探讨二型胃癌不同生物学特性的分子学基础.方法:采用免疫组化SP法检测Bcl-2/Bax,cathepsin-D(Cath-D)和VEGF在胃癌及正常胃组织的表达.结果:Bcl-2/Bax,Cath-D和VEGF阳性表达率在胃癌组织中与癌旁正常胃黏膜组织中比较(分别为44.59%vs27.30%;58.11%vs71.62%;77.00%vs21.60%;71.62%vs14.86%)均有显著性差异(P＜0.05),弥漫型胃癌中Bcl-2和Cath-D阳性细胞指数明显高于肠型胃癌(分别为29.14±24.70vs19.80±27.37和52.59±33.76 vs 29.21±39.67),而Bax阳性细胞指数(分别为32.56±35.55vs47.74±27.43)明显低于肠型胃癌,差异均有显著性(P＜0.05),VEGF阳性细胞表达指数在不同胃癌浸润深度组间比较(早期胃癌7.13±15.81vs肌层浸润62.77±44.37vs浆膜浸润40.82±42.70)及有无淋巴结转移组间比较(42.05±42.61 vs 34.15±42.52)有显著性差异(P＜0.05).结论:Bcl-2/Bax,Cath-D和VEGF分别参与了胃癌的发生,浸润进展和转移.二型胃癌在组织学发生相同的基础上由于在胃癌演进过程中有不同附加基因参与(Bcl-2/Bax和Cath-D),使弥漫型胃癌获得了与肠型胃癌有所不同的亚克隆过程,因而表现为生物学特性的异质化.
- [1]徐佶,张一楚,孙久运,等.bcl-2,bax,Ki-67在胃癌中的表达及意义[J].2001,(3).
- [2]W L, McGuire,A K, Tandon,D C, Allred,etc.Prognosis and treatment decisions in patients with breast cancer without axillary node involvement.[J].1992,70.
- [3]O, Melnyk,M A, Shuman,K J, Kim.Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth.[J].1996,56.
- [4]PEKKA LAURÉN.The Two Histological Main Types of Gastric Carcinoma: Diffuse and so-Called Intestinal-Type Carcinoma[J].1965,64(1).
- [5]M, Saegusa,Y, Takano,T, Wakabayashi,etc.Apoptosis in gastric carcinomas and its association with cell proliferation and differentiation.[J].1995,86.
- [6]M, Garcia,D, Derocq,P, Pujol,etc.Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency.[J].1990,5.
- [7]W, Müller,A, Schneiders,G, Hommel,etc.Prognostic value of bcl-2 expression in gastric cancer.[J].1900,18.
- [8]Harmey JH,Bouchier-Hayes D.Vascular endothelial growth factor (VEGF), a survival factor for tumour cells: implications for anti-angiogenic therapy[J].2002,24(3).
- [9]N, Kasagi,Y, Gomyo,H, Shirai,etc.Apoptotic cell death in human gastric carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling.[J].1994,85.
- [10]Gaci M,Ingrand P,Gaci Z,etc.Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.[J].2001,18(4).
- [11]L F, Brown,B, Berse,R W, Jackman,etc.Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer.[J].1995,26(1).
- [12]Gutmann DH,Vogelbaum MA,Higashikubo R,etc.Transfection of C6 glioma cells with the bax gene and increased sensitivity to treatment with cytosine arabinoside.[J].1998,88(1).
- [13]D, Chalbos,B, Westley,F, May,etc.Cloning of cDNA sequences of a progestin-regulated mRNA from MCF7 human breast cancer cells.[J].1986,14.
- [14]P A, Hall,P J, Coates,B, Ansari,etc.Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis.[J].1994,107 ( Pt 12).
- [15]K, Maeda,Y S, Chung,Y, Ogawa,etc.Prognostic value of vascular endothelial growth factor expression in gastric carcinoma.[J].1996,77(5).